Adult T-cell leukemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adult T-cell leukemia}} | {{Adult T-cell leukemia}} | ||
{{CMG}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | |||
==Medical Therapy== | ==Medical Therapy== | ||
==References== | ==References== | ||
{{Reflist|1}} | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pathology]] | [[Category:Pathology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] |
Revision as of 16:25, 25 January 2016
Adult T-cell leukemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Adult T-cell leukemia medical therapy On the Web |
American Roentgen Ray Society Images of Adult T-cell leukemia medical therapy |
Risk calculators and risk factors for Adult T-cell leukemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]